Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/25/2025

Escitalopram Dosing Guidelines

Standard Dosing for Depression and Anxiety

  • The American Academy of Pediatrics recommends a starting dose of 10 mg once daily for adolescents (12 years and older) with depression, which may be increased to 20 mg after a minimum of three weeks 2
  • The maximum dose for adolescents (12 years and older) with depression is 20 mg daily 2
  • Escitalopram is FDA-approved for adolescents aged 12+ with depression, but not for children under 12 or for anxiety disorders in adolescents 2

Special Populations Requiring Dose Reduction

  • Elderly patients (>60 years) have an increased sensitivity to adverse effects and higher cardiac risk, particularly QT prolongation, and should be dosed at 10 mg daily maximum 1, 3

Key Safety Considerations

  • The risk of QT prolongation increases with doses above 20 mg, and a baseline ECG should be obtained in patients over 40 years or with cardiac history before initiating treatment 1, 3
  • Patients should avoid combining escitalopram with other QT-prolonging medications without careful monitoring 3

Discontinuation Protocol

  • The American College of Clinical Pharmacology recommends reducing the dose incrementally (e.g., by 5 mg every 1-2 weeks) to minimize discontinuation symptoms 1

When Maximum Dose is Insufficient

  • If 20 mg daily provides inadequate response, consider augmentation strategies rather than exceeding 20 mg, such as adding bupropion or mirtazapine 1
  • Switch to SNRI if somatic symptoms are prominent, such as venlafaxine (up to 225 mg daily) or duloxetine 1, 3, 4
  • Never exceed 20 mg daily due to lack of FDA approval and increased cardiac risk 1

REFERENCES

2

Managing Escitalopram Dosage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Dose Adjustment Recommendations for Generalized Anxiety Disorder [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Refractory Anxiety on Multi-Drug Regimen [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025